The reverse-direction method links mass experimental data to human diseases.
The reverse-direction method links mass experimental data to human diseases.
复制标题
反向方法将大量实验数据与人类疾病联系起来。
DOI:
10.1007/s00005-013-0255-9
复制
发表时间:
2014
影响因子:
3.2
通讯作者:
M
中科院分区:
文献类型:
--
作者:
Ogura;H.;Atsumi;T.;Bando;H.;Sabharwal;L.;Yamada;M.;Jiang;J. J.;Nakamura;A.;Arima;Y.;Kamimura;D. & Murakami;M
Genome-wide analyses such as DNA microarray, RNA sequencing and RNA interference-based high-throughput screening are prevalent to decipher a biological process of interest, and provide a large quantity of data to be processed. An ultimate goal for researchers must be extrapolation of their data to human diseases. We have conducted functional genome-wide screenings to elucidate molecular mechanisms of the inflammation amplifier, a NFκB/STAT3-dependent machinery that potently drives recruitment of immune cells to promote inflammation. Using a public database of genome-wide association studies (GWAS), we recently reported the reverse-direction method by which our mass screening data were successfully linked to many human diseases. As an example, the epiregulin–epidermal growth factor receptor pathway was identified as a regulator of the inflammation amplifier, and associated with human diseases by GWAS. In fact, serum epiregulin levels were higher in patients with chronic inflammatory disorders. The reverse-direction method can be a useful tool to narrow mass data down to focus on human disease-related genes.